| Effect of sibutramine on weight maintenance after weight loss: a randomised trial* WPT James, A Astrup, N Finer, J Hilsted, P Kopelman, S Rössner, ... The Lancet 356 (9248), 2119-2125, 2000 | 1206 | 2000 |
| Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ... New England Journal of Medicine 363 (10), 905-917, 2010 | 1199 | 2010 |
| Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide A Astrup, R Carraro, N Finer, A Harper, M Kunesova, MEJ Lean, ... International journal of obesity 36 (6), 843-854, 2012 | 985* | 2012 |
| Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study AJ Scheen, N Finer, P Hollander, MD Jensen, LF Van Gaal The lancet 368 (9548), 1660-1672, 2006 | 947 | 2006 |
| Management of Obesity in Adults: European Clinical Practice Guidelines T Constantine, V Hainer, A Basdevant, N Finer, M Fried, ... The European Journal of Obesity 1 (106), 10.1159, 0 | 785* | |
| Redefining type 2 diabetes:‘diabesity’or ‘obesity dependent diabetes mellitus’? A Astrup, N Finer obesity reviews 1 (2), 57-59, 2000 | 643 | 2000 |
| Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES) S Sauerland, L Angrisani, M Belachew, JM Chevallier, F Favretti, N Finer, ... Surgical endoscopy 19 (2), 200-221, 2005 | 522 | 2005 |
| One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. N Finer, WP James, PG Kopelman, ME Lean, G Williams International journal of obesity and related metabolic disorders: journal of …, 2000 | 406 | 2000 |
| A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism WM Kong, MH Sheikh, PJ Lumb, DB Freedman, M Crook, CJ Doré, ... The American journal of medicine 112 (5), 348-354, 2002 | 353 | 2002 |
| Inter-disciplinary European guidelines on surgery of severe obesity M Fried, V Hainer, A Basdevant, H Buchwald, M Deitel, N Finer, ... International Journal of obesity 31 (4), 569-577, 2007 | 351 | 2007 |
| Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline EMH Mathus-Vliegen, A Basdevant, N Finer, V Hainer, H Hauner, D Micic, ... Obesity facts 5 (3), 460-483, 2012 | 340 | 2012 |
| Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non … A Yousseif, J Emmanuel, E Karra, Q Millet, M Elkalaawy, AD Jenkinson, ... Obesity surgery 24, 241-252, 2014 | 311 | 2014 |
| Interdisciplinary European guidelines on surgery of severe obesity M Fried, V Hainer, A Basdevant, H Buchwald, M Deitel, N Finer, JW Greve, ... Obesity facts 1 (1), 52-59, 2008 | 285 | 2008 |
| Interdisciplinary European guidelines for surgery for severe (morbid) obesity M Fried, V Hainer, A Basdevant, H Buchwald, M Deitel, N Finer, ... Obesity surgery 17, 260-270, 2007 | 278 | 2007 |
| Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double‐blind, placebo‐controlled study N Finer, SR Bloom, GS Frost, LM Banks, J Griffiths Diabetes, Obesity and Metabolism 2 (2), 105-112, 2000 | 269 | 2000 |
| Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension J Jordan, V Yumuk, M Schlaich, PM Nilsson, B Zahorska-Markiewicz, ... Journal of hypertension 30 (6), 1047-1055, 2012 | 244 | 2012 |
| Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children E Falaschetti, AD Hingorani, A Jones, M Charakida, N Finer, P Whincup, ... European heart journal 31 (24), 3063-3072, 2010 | 235 | 2010 |
| Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta‐analysis E Zomer, K Gurusamy, R Leach, C Trimmer, T Lobstein, S Morris, ... Obesity reviews 17 (10), 1001-1011, 2016 | 228 | 2016 |
| Drug interventions for the treatment of obesity in children and adolescents E Axon, G Atkinson, B Richter, MI Metzendorf, L Baur, N Finer, ... Cochrane Database of Systematic Reviews 2020 (3), 1996 | 202 | 1996 |
| Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA M Lopez, CJ Lelliott, S Tovar, W Kimber, R Gallego, S Virtue, M Blount, ... Diabetes 55 (5), 1327-1336, 2006 | 188 | 2006 |
Gary WittertProfessor of Medicine, University of AdelaideDirección de correo verificada de adelaide.edu.au
